The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Topper, David Joseph
    Chief Financial Officer born in June 1957
    Individual (1 offspring)
    Officer
    2024-09-30 ~ now
    OF - director → CIF 0
  • 2
    Matsuda, Masaru
    General Counsel born in March 1970
    Individual (1 offspring)
    Officer
    2023-12-06 ~ now
    OF - director → CIF 0
  • 3
    Burnett, Patrick
    Chief Medical Officer born in May 1971
    Individual (1 offspring)
    Officer
    2022-09-09 ~ now
    OF - director → CIF 0
  • 4
    3411 Silverside Road, 19810, 3411 Silverside Road, Tatnall Building #104, Wilmington, Delaware, United States
    Corporate (1 offspring)
    Person with significant control
    2022-09-09 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 13
  • 1
    Morris, Toby
    Individual
    Officer
    2014-11-12 ~ 2015-05-01
    OF - secretary → CIF 0
  • 2
    Holbrook, David Mark Anthony, Dr
    Head Of Seed Funds At Lifearc born in May 1960
    Individual (7 offsprings)
    Officer
    2019-06-12 ~ 2021-04-28
    OF - director → CIF 0
    Dr David Mark Anthony Holbrook
    Born in May 1960
    Individual (7 offsprings)
    Person with significant control
    2019-06-14 ~ 2021-04-28
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firm → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firm → CIF 0
  • 3
    Watt, Alan Paul, Dr
    Cso born in September 1963
    Individual (10 offsprings)
    Officer
    2021-08-06 ~ 2022-09-09
    OF - director → CIF 0
  • 4
    Burrows, Scott Loren
    Chief Financial Officer born in March 1977
    Individual (1 offspring)
    Officer
    2022-09-09 ~ 2023-08-31
    OF - director → CIF 0
  • 5
    Terlouw, Clare Elizabeth
    Head Of Ventures, Life Arc born in December 1973
    Individual (9 offsprings)
    Officer
    2021-06-10 ~ 2022-09-09
    OF - director → CIF 0
  • 6
    Mica, Andrea Giacomo
    Director At Oxford Technology Management born in January 1968
    Individual (5 offsprings)
    Officer
    2019-06-12 ~ 2022-09-09
    OF - director → CIF 0
  • 7
    Blackbourn, David John, Professor
    University Professor born in October 1964
    Individual (1 offspring)
    Officer
    2015-07-09 ~ 2022-09-09
    OF - director → CIF 0
  • 8
    Ashfield, Rebecca, Dr
    Research Scientist born in January 1967
    Individual
    Officer
    2015-07-09 ~ 2022-09-09
    OF - director → CIF 0
  • 9
    Robison, Jessica Lynn
    Vice President born in August 1982
    Individual
    Officer
    2023-12-06 ~ 2024-08-21
    OF - director → CIF 0
  • 10
    Huxley, Philip, Dr
    R&D born in November 1956
    Individual (2 offsprings)
    Officer
    2014-11-12 ~ 2022-09-09
    OF - director → CIF 0
    Huxley, Philip, Dr
    Individual (2 offsprings)
    Officer
    2015-05-02 ~ 2022-09-09
    OF - secretary → CIF 0
    Dr Philip Huxley
    Born in November 1956
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2022-09-09
    PE - Has significant influence or control → CIF 0
  • 11
    Moore, Matthew
    Chief Business Officer born in October 1972
    Individual
    Officer
    2022-09-09 ~ 2024-05-15
    OF - director → CIF 0
  • 12
    Lenoble, Philippe
    Investor born in November 1971
    Individual (1 offspring)
    Officer
    2019-06-12 ~ 2022-09-09
    OF - director → CIF 0
  • 13
    Lynton House, 7-12 Tavistock Square, London, United Kingdom
    Corporate
    Person with significant control
    2019-08-06 ~ 2022-09-09
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

DUCENTIS BIOTHERAPEUTICS LTD.

Previous names
TRIPOS BIOPHARMA LTD. - 2015-07-06
DUCENTIS BIOTHERAPEUTICS LTD. - 2015-05-08
DEUCENTIS LIMITED - 2014-11-17
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
106,708 GBP2023-12-31
1,614 GBP2022-10-31
Cash at bank and in hand
4,017 GBP2023-12-31
26,990 GBP2022-10-31
Current Assets
110,725 GBP2023-12-31
28,604 GBP2022-10-31
Creditors
Current, Amounts falling due within one year
-3,321,201 GBP2023-12-31
-23,996 GBP2022-10-31
Net Current Assets/Liabilities
-3,210,476 GBP2023-12-31
4,608 GBP2022-10-31
Equity
Called up share capital
975 GBP2023-12-31
975 GBP2022-10-31
685 GBP2021-10-31
Share premium
6,114,317 GBP2023-12-31
6,114,317 GBP2022-10-31
3,003,291 GBP2021-10-31
Other miscellaneous reserve
757,032 GBP2023-12-31
757,032 GBP2022-10-31
0 GBP2021-10-31
Retained earnings (accumulated losses)
-10,082,800 GBP2023-12-31
-6,867,716 GBP2022-10-31
-3,661,400 GBP2021-10-31
Equity
-3,210,476 GBP2023-12-31
4,608 GBP2022-10-31
-657,424 GBP2021-10-31
Profit/Loss
Retained earnings (accumulated losses)
-3,215,084 GBP2022-11-01 ~ 2023-12-31
-3,206,316 GBP2021-11-01 ~ 2022-10-31
Profit/Loss
-3,215,084 GBP2022-11-01 ~ 2023-12-31
-3,206,316 GBP2021-11-01 ~ 2022-10-31
Issue of Equity Instruments
Called up share capital
290 GBP2021-11-01 ~ 2022-10-31
Issue of Equity Instruments
3,111,316 GBP2021-11-01 ~ 2022-10-31
Average Number of Employees
22022-11-01 ~ 2023-12-31
22021-11-01 ~ 2022-10-31
Other Debtors
Amounts falling due within one year
106,708 GBP2023-12-31
1,614 GBP2022-10-31
Trade Creditors/Trade Payables
Current
872 GBP2023-12-31
5,766 GBP2022-10-31
Other Taxation & Social Security Payable
Current
82,613 GBP2023-12-31
0 GBP2022-10-31
Other Creditors
Current
3,237,716 GBP2023-12-31
18,230 GBP2022-10-31
Equity
Called up share capital
975 GBP2023-12-31
975 GBP2022-10-31
  • DUCENTIS BIOTHERAPEUTICS LTD.
    Info
    TRIPOS BIOPHARMA LTD. - 2015-07-06
    DUCENTIS BIOTHERAPEUTICS LTD. - 2015-05-08
    DEUCENTIS LIMITED - 2014-11-17
    Registered number 09307415
    Suite 2 First Floor, 10 Temple Back, Bristol BS1 6FL
    Private Limited Company incorporated on 2014-11-12 (10 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.